Outlook Therapeutics
OTLK
$8.50
Share price
-4.71%
Change (1 day)
626.50%
Change (1 year)
Categories
Outlook Therapeutics (OTLK) - Total debt
Total debt on the balance sheet as of December 2023 : $36.54 M
According to Outlook Therapeutics 's latest financial reports the company's total debt is $36.54 M. A company’s total debt is the sum of all current and non-current debts.
Outlook Therapeutics - Total debt on balance sheet (from 2015 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-09-30 | $35.55 M | 224.47% |
| 2022-09-30 | $10.95 M | -7.93% |
| 2021-09-30 | $11.9 M | 35.29% |
| 2020-09-30 | $8.79 M | -41.14% |
| 2019-09-30 | $14.94 M | -31.85% |
| 2018-09-30 | $21.93 M | 19.08% |
| 2017-09-30 | $18.41 M | 110.95% |
| 2016-09-30 | $8.73 M | -60.25% |
| 2015-09-30 | $21.96 M | 0% |
| 2014-09-30 | $21.96 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $1.5 M | -95.89% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $47.82 M | 30.85% | 🇬🇧 UK |
 Novavax NVAX | $0.22 B | 526.84% | 🇺🇸 USA |
 Novocure
NVCR | $0.59 B | 1,531.52% | Jersey |